home

conferences

euretina

EURETINA

Sheryl brings a wealth of editorial experience to MJH Life Sciences’ Eye Care Network, having engaged with the readers and the greater ophthalmic community of 

for more than 20 years. As Group Editorial Director, Sheryl’s purview extends across the print and digital network of 

Ophthalmology Times, Ophthalmology Times Europe, Modern Retina 

 Prior to ophthalmology, Sheryl previously covered the fields of audiology and confectionery science/technology/manufacturing.

Sheryl is also passionate about the mission, vision and values of Ophthalmic World Leaders (OWL) and recently completed her term on its Board of Directors. She continues to volunteer as Editor-in-Chief of the organization’s 

Magazine. In 2013, she was honored with the group’s inaugural Rising Star Award.

In addition, she has served as a judge for 

 Health Care Heroes Awards program as well as the Jesse H. Neal National Business Journalism Awards.

Videos


Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.

Investigating suitable naïve versus pre-treated DME patients

Articles

Anat Loewenstein, MD, MHA, discusses how artificial intelligence can optimize optical coherence tomography. 

AI: Capturing more information from OCT in wet AMD

A case study details the care of a patient who had already lost vision in one eye from a similar issue. 

Challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy 

Carel B. Hoyng, MD, discusses his presenation regarding macula dystrophies, including Stargardt disease, Best disease, X-linked retinoschisis, and the peripherin-2 (PRPH2) gene.


Analyzing macula dystrophy classifications 

José-Alain Sahel, MD, explains how optogenetics involves artificial photoreceptors from specific retinal cells to restore vision.

Optogenetic therapy: Gene-independent therapeutic strategies for retinal degeneration

Ramin Tadayoni, MD, PhD, discusses the pathology of myopia around the globe.

Exploring the pathology of myopia from a global perspective

Jennifer Sun, MD, MPH, explores the question of whether ophthalmologists should be using anti-VEGF agents to treat patients with nonproliferative diabetic retinopathy (NPDR).

Should anti-VEGF agents be used to treat NPDR patients?

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery. 

Study targets intravitreal injections for AMD, PCR risks

Tunde Peto, MD, offers advice on how to create the best virtual environment for patients diagnosed with diabetic eye disease.

Providing virtual care for diabetic eye disease patients

Pertile is the head of the Department of Ophthalmology, Sacrocuore Hospital, in Negrar-Verona, Italy.

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.